Home › NDC Lookup › RxCUI directory › RxCUI 314142

Nateglinide 60 MG Oral Tablet — RxCUI 314142

RxNorm drug concept · Semantic clinical drug
RxCUI 314142 Semantic clinical drug · SCD ● Current RxNorm concept 20 FDA products 57 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI314142
Official nameNateglinide 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped20
Package NDCs mapped57
Reported Medicaid activity (SDUD)11,605 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nateglinide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nateglinide helps your pancreas release insulin right after you eat, which keeps your blood sugar from spiking too high after meals. It's specifically for type 2 diabetes and is me...
  • What exactly does nateglinide do for my diabetes?
  • Take it 1 to 30 minutes before each meal — three times a day. Timing matters here because it's designed to match your body's insulin release with the food you're about to eat. If y...
  • When exactly should I take my nateglinide tablet?
📖 Read our full Nateglinide guide →

🕸️ Concept Web — How Nateglinide 60 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nateglinide 60 MG Oral Tablet RxCUI 314142

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nateglinide 274332
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nateglinide Oral Tablet 374648
    • Nateglinide Oral Product 1158396
    • Nateglinide Pill 1158397
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Nateglinide 60 MG 330386

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nateglinide 60 MG SCDC · 330386
  • Nateglinide Oral Tablet SCDF · 374648
  • Nateglinide Oral Product SCDG · 1158396
  • Nateglinide Pill SCDG · 1158397

📦 FDA Products & Package NDCs

20 products · 57 package NDCs
57 package NDCs map to RxCUI 314142 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16571-0758-01 100 TABLET in 1 BOTTLE (16571-758-01) NATEGLINIDE Rising Pharma Holdings, Inc. 2020-12-16
16571-0758-09 90 TABLET in 1 BOTTLE (16571-758-09) NATEGLINIDE Rising Pharma Holdings, Inc. 2020-12-16
16571-0758-50 500 TABLET in 1 BOTTLE (16571-758-50) NATEGLINIDE Rising Pharma Holdings, Inc. 2020-12-16
16571-0759-01 100 TABLET in 1 BOTTLE (16571-759-01) NATEGLINIDE Rising Pharma Holdings, Inc. 2020-12-16
16571-0759-09 90 TABLET in 1 BOTTLE (16571-759-09) NATEGLINIDE Rising Pharma Holdings, Inc. 2020-12-16
16571-0759-50 500 TABLET in 1 BOTTLE (16571-759-50) NATEGLINIDE Rising Pharma Holdings, Inc. 2020-12-16
51407-0656-01 100 TABLET in 1 BOTTLE, PLASTIC (51407-656-01) Nateglinide Golden State Medical Supply, Inc. 2022-05-25
51407-0657-01 100 TABLET in 1 BOTTLE, PLASTIC (51407-657-01) Nateglinide Golden State Medical Supply, Inc. 2022-05-25
55111-0328-01 100 TABLET in 1 BOTTLE (55111-328-01) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0328-05 500 TABLET in 1 BOTTLE (55111-328-05) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0328-30 30 TABLET in 1 BOTTLE (55111-328-30) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0328-78 10 BLISTER PACK in 1 CARTON (55111-328-78) / 10 TABLET in 1... Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0328-90 90 TABLET in 1 BOTTLE (55111-328-90) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0329-01 100 TABLET in 1 BOTTLE (55111-329-01) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0329-05 500 TABLET in 1 BOTTLE (55111-329-05) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0329-30 30 TABLET in 1 BOTTLE (55111-329-30) Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
55111-0329-78 10 BLISTER PACK in 1 CARTON (55111-329-78) / 10 TABLET in 1... Nateglinide Dr. Reddy's Laboratories Limited 2009-09-09
60687-0673-21 30 BLISTER PACK in 1 CARTON (60687-673-21) / 1 TABLET in 1... Nateglinide American Health Packaging 2023-01-12
60687-0684-21 30 BLISTER PACK in 1 CARTON (60687-684-21) / 1 TABLET in 1... Nateglinide American Health Packaging 2023-01-03
64380-0167-01 100 TABLET in 1 BOTTLE, PLASTIC (64380-167-01) Nateglinide Strides Pharma Science Limited 2022-05-09
64380-0167-02 90 TABLET in 1 BOTTLE, PLASTIC (64380-167-02) Nateglinide Strides Pharma Science Limited 2022-09-07
64380-0168-01 100 TABLET in 1 BOTTLE, PLASTIC (64380-168-01) Nateglinide Strides Pharma Science Limited 2022-05-09
64380-0168-02 90 TABLET in 1 BOTTLE, PLASTIC (64380-168-02) Nateglinide Strides Pharma Science Limited 2022-09-07
68382-0721-01 100 TABLET, FILM COATED in 1 BOTTLE (68382-721-01) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0721-05 500 TABLET, FILM COATED in 1 BOTTLE (68382-721-05) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0721-06 30 TABLET, FILM COATED in 1 BOTTLE (68382-721-06) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0721-10 1000 TABLET, FILM COATED in 1 BOTTLE (68382-721-10) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0721-16 90 TABLET, FILM COATED in 1 BOTTLE (68382-721-16) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0721-77 10 BLISTER PACK in 1 CARTON (68382-721-77) / 10 TABLET, FIL... Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0722-01 100 TABLET, FILM COATED in 1 BOTTLE (68382-722-01) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0722-05 500 TABLET, FILM COATED in 1 BOTTLE (68382-722-05) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0722-06 30 TABLET, FILM COATED in 1 BOTTLE (68382-722-06) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0722-10 1000 TABLET, FILM COATED in 1 BOTTLE (68382-722-10) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0722-16 90 TABLET, FILM COATED in 1 BOTTLE (68382-722-16) Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
68382-0722-77 10 BLISTER PACK in 1 CARTON (68382-722-77) / 10 TABLET, FIL... Nateglinide Zydus Pharmaceuticals USA Inc. 2016-10-27
70771-1015-00 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1015-0) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1015-01 100 TABLET, FILM COATED in 1 BOTTLE (70771-1015-1) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1015-03 30 TABLET, FILM COATED in 1 BOTTLE (70771-1015-3) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1015-04 10 BLISTER PACK in 1 CARTON (70771-1015-4) / 10 TABLET, FIL... Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1015-05 500 TABLET, FILM COATED in 1 BOTTLE (70771-1015-5) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1015-09 90 TABLET, FILM COATED in 1 BOTTLE (70771-1015-9) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1016-00 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1016-0) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1016-01 100 TABLET, FILM COATED in 1 BOTTLE (70771-1016-1) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1016-03 30 TABLET, FILM COATED in 1 BOTTLE (70771-1016-3) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1016-04 10 BLISTER PACK in 1 CARTON (70771-1016-4) / 10 TABLET, FIL... Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1016-05 500 TABLET, FILM COATED in 1 BOTTLE (70771-1016-5) Nateglinide Zydus Lifesciences Limited 2016-10-27
70771-1016-09 90 TABLET, FILM COATED in 1 BOTTLE (70771-1016-9) Nateglinide Zydus Lifesciences Limited 2016-10-27
71209-0030-04 90 TABLET, COATED in 1 BOTTLE (71209-030-04) Nateglinide Cadila Pharmaceuticals Limited 2020-12-17
71209-0030-05 100 TABLET, COATED in 1 BOTTLE (71209-030-05) Nateglinide Cadila Pharmaceuticals Limited 2014-02-10
71209-0031-04 90 TABLET, COATED in 1 BOTTLE (71209-031-04) Nateglinide Cadila Pharmaceuticals Limited 2020-12-17
Observed labelers: Zydus Lifesciences Limited (12) · Zydus Pharmaceuticals USA Inc. (12) · Dr. Reddy's Laboratories Limited (9) · Rising Pharma Holdings, Inc. (6) · Cadila Pharmaceuticals Limited (4) · Modavar Pharmaceuticals LLC (4) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.